CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Acclarent Tympanostomy Tube Delivery System (TTDS).device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02150044
NCT02150044N/ACompleted
CompareCT.gov

A Clinical Study of the Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion for Otitis Media

Integra LifeSciences Corporation·interventional·Posted May 29, 2014·Updated Jul 12, 2024

In Brief

A clinical study evaluating Acclarent Tympanostomy Tube Delivery System (TTDS). for Otitis Media. Completed, enrolled 29 participants across 1 site.

Detailed Summary

This was a non-significant risk (NSR), prospective, multi-center, single arm clinical trial that aimed to evaluate safety and performance of the Acclarent Tympanostomy Tube Delivery System (TTDS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOtitis Media
CountriesUnited States
CollaboratorsAcclarent

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 29, 2014
Enrollment StartFeb 1, 2010
Primary CompletionOct 1, 2010
Study CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.1 years ago

Interventions

Acclarent Tympanostomy Tube Delivery System (TTDS).device

tympanostomy tube delivery system